ZA907348B - Method of administering soluble t4 for treatment of human immunodeficiency virus infection - Google Patents

Method of administering soluble t4 for treatment of human immunodeficiency virus infection

Info

Publication number
ZA907348B
ZA907348B ZA907348A ZA907348A ZA907348B ZA 907348 B ZA907348 B ZA 907348B ZA 907348 A ZA907348 A ZA 907348A ZA 907348 A ZA907348 A ZA 907348A ZA 907348 B ZA907348 B ZA 907348B
Authority
ZA
South Africa
Prior art keywords
treatment
immunodeficiency virus
virus infection
human immunodeficiency
administering soluble
Prior art date
Application number
ZA907348A
Inventor
Randall T Curnow
Johannes Jukna
T Curnow Randall
Jukna Johannes
Original Assignee
Smithkline Beecham Corp
Beecham Wuelfing Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Beecham Wuelfing Gmbh & Co Kg filed Critical Smithkline Beecham Corp
Publication of ZA907348B publication Critical patent/ZA907348B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA907348A 1989-09-18 1990-09-17 Method of administering soluble t4 for treatment of human immunodeficiency virus infection ZA907348B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40861789A 1989-09-18 1989-09-18

Publications (1)

Publication Number Publication Date
ZA907348B true ZA907348B (en) 1991-10-30

Family

ID=23617014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907348A ZA907348B (en) 1989-09-18 1990-09-17 Method of administering soluble t4 for treatment of human immunodeficiency virus infection

Country Status (4)

Country Link
AU (1) AU6447690A (en)
IE (1) IE903344A1 (en)
WO (1) WO1991004044A1 (en)
ZA (1) ZA907348B (en)

Also Published As

Publication number Publication date
WO1991004044A1 (en) 1991-04-04
AU6447690A (en) 1991-04-18
IE903344A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
HUT46542A (en) Process for production of medical preparatives containing bifilar rns and virus-inhibitors applicable for human treatment of virus infection
HU9202616D0 (en) Method for preparing pharmaceutical preparatives serving for treatment of congestive heart diseases
AP9000206A0 (en) Treatment of conditions & diseases
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
IL95813A0 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
AU6974687A (en) Treatment of immune diseases using diphenylhydantoin
ZA892308B (en) Method of treating retrovirus infection
ZA903258B (en) Method of suppressing hiv infection
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
IE883793L (en) Method of inhibiting human immunodeficiency virus
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
ZA907348B (en) Method of administering soluble t4 for treatment of human immunodeficiency virus infection
AU6877991A (en) A method of inactivating human immunodeficiency virus
ZA888822B (en) Agents for removing human immunodeficiency virus and/or its related compounds
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
AU4660889A (en) Method of treatment of human immunodeficiency virus
PH27412A (en) Method of treatment of human immunodeficiency virus
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
GB8814032D0 (en) Treatment of patients having aids virus & apparatus for use in said treatment
IE892593L (en) Treatment of virus diseases
GB9216360D0 (en) Treatment of blood
AU1792788A (en) Rubradirin derivatives for treatment of hiv infection
GB8910063D0 (en) Treatment of patients having aids virus and apparatus for use in said treatment